Funded Tech Companies

Incyclix Bio

Headquartered in Triangle Park, Incyclix Bio is venture-backed, with investment from Eshelman Ventures, Boxer Capital and RA Capital.

Company Overview

Company Name
Incyclix Bio
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
600 Park Offices Drive Suite 355 Research
Triangle Park, NC 27709
USA
Email Address

Company Background Information

Overview
Developer of small molecule inhibitors of cyclin-dependent kinases (CDKs) intended to provide treatment for patients with advanced and resistant cancers. The company's inhibitors help to achieve the potent and selective inhibition of elusive CDK targets, enabling pharmaceutical companies and medical practitioners with novel drugs to help and improve the treatment of cancer patients.
Profile
Incyclix Bio LinkedIn Company Profile
Social Media
Incyclix Bio Company Twitter Account
Company News
Incyclix Bio News
Facebook
Incyclix Bio on Facebook
YouTube
Incyclix Bio on YouTube
Last Transaction
3/31/2022

Financing History

Date
Type
Amount
Venture Equity
$30,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Patrick Roberts
  Patrick Roberts LinkedIn Profile  Patrick Roberts Twitter Account  Patrick Roberts News  Patrick Roberts on Facebook
Co-Founder
Jay Strum
  Jay Strum LinkedIn Profile  Jay Strum Twitter Account  Jay Strum News  Jay Strum on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Incurrent Solutions | Incysus Therapeutics

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary